Ming Guo, M.D., Ph.D., is P. Gene & Elaine Smith Chair in Alzheimer’s Disease Research, UCLA Professor of Neurology, Molecular and Medical Pharmacology. She sees internationally referred patients with neurological disorders (Middle East, China, India, Southeast Asia, Europe and South America), with an emphasis on brain degenerative diseases including Alzheimer’s (AD) and Parkinson’s disease (PD). She runs a basic and translational research laboratory at UCLA with a major focus on neurodegenerative diseases and neural regeneration. She is Director of a campus-wide, cross-disciplinary, the National Institutes of Health-funded Aging Center at UCLA.
Dr. Guo is a sought-after speaker nationally and internationally. She has received numerous awards, including the Alfred P. Sloan Foundation Fellowship; the Brain Disorders Awards from the McKnight Foundation; the Klingenstein Simons Fellowship Awards; the Robert H. Ebert Clinical Scholar Award (given to one awardee each year); the American Neurological Association (ANA) Derek Denny Brown Neurological Scholar Award (given to one or two awardees each year); Ellison Medical Foundation Senior Scholar Award on Aging; the National Institutes of Health Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) award. She also received the John H. Walsh Young Investigator Research Prize, which is given to one young UCLA faculty member every three years for significant contributions to research. She is an elected member of the prestigious Association of American Physicians (AAP) which is an honorary society founded in 1885 by Sir William Osler. Selection to AAP is “an indication of the pre-eminence and the highest caliber of physician-led science accomplishments and scientific leadership”.
Dr. Guo is actively involved in leadership activities in the medical and scientific communities. Dr. Guo is a board member of the McKnight Neuroscience Foundation, and serves as Chair of their selection committee for Neurobiology of Brain Disorders Award. She serves on the Scientific Advisory Committee for A.P. Giannini Foundation, and the Editorial Board of Aging Cell and Current Opinion in Neurobiology. She has served as Chair of the Board of Scientific Counselors at the National Institute of Neurological Disorders and Stroke (NINDS). The board provides oversight for the NINDS Intramural Research Program, which utilizes $150 million per year and advises institute directors on science, budgets and space allocation. She serves as a Board of Director of ANA, which is a professional society of academic neurologists and neuroscientists devoted to academic neurology in education, research and patient care.